Add Yahoo as a preferred source to see more of our stories on Google. 23andMe headquarters in Sunnyvale, Calif. (Tayfun Coskun/Anadolu via Getty Images) Today is the deadline for customers of the ...

Valerie is a seasoned writer and editor who has spent her career creating content in the parenting and women's wellness spaces. Before joining Forbes Health, Valerie was the trending news editor at ...

Add Yahoo as a preferred source to see more of our stories on Google. Close-up of collection kit for personal genomics technology company 23AndMe on a retail store shelf, March 18, 2019. (Courtesy of ...

23andMe, known for its at-home DNA testing kits, is expected to be obtained by its highest bidder following a bankruptcy auction after reaching a peak valuation of $6 billion. On Monday, 23andMe ...

Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing company running without interruption and uphold its privacy-protection ...

WASHINGTON (AP) -- Genetic testing company 23andMe is reintroducing some health screening tools that federal regulators forced off the market more than two years ago, due to concerns about their ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min 23andMe bought high — as Covid ...

Beth Skwarecki is Lifehacker’s Senior Health Editor, and holds certifications as a personal trainer and weightlifting coach. She has been writing about health for over 10 years. A judge has finally ...

Genetic testing company 23andMe agreed to pay $18 million to resolve a multistate data breach lawsuit stemming from a massive 2023 data breach that affected nearly 7 million individuals worldwide. In ...

Anne Wojcicki, cofounder and former CEO of 23andMe, will regain control of the company after her nonprofit, TTAM Research Institute, agreed to purchase nearly all of its assets for $305 million. In ...

From the San Francisco Business Times: An investment firm believes it can make financial lemonade out a soured 23andMe asset if a U.S. Bankruptcy Court judge approves the sale of telemedicine company ...